Liaoning Cheng Da Co., Ltd. (600739.SS)

CNY 11.01

(-0.63%)

EBITDA Summary of Liaoning Cheng Da Co., Ltd.

  • Liaoning Cheng Da Co., Ltd.'s latest annual EBITDA in 2023 was 465.75 Million CNY , down -92.16% from previous year.
  • Liaoning Cheng Da Co., Ltd.'s latest quarterly EBITDA in 2024 Q3 was 783.07 Million CNY , up 236.25% from previous quarter.
  • Liaoning Cheng Da Co., Ltd. reported an annual EBITDA of 1.24 Billion CNY in 2022, down -2.52% from previous year.
  • Liaoning Cheng Da Co., Ltd. reported an annual EBITDA of 3 Billion CNY in 2021, down -30.91% from previous year.
  • Liaoning Cheng Da Co., Ltd. reported a quarterly EBITDA of 298.06 Million CNY for 2024 Q1, up 125.36% from previous quarter.
  • Liaoning Cheng Da Co., Ltd. reported a quarterly EBITDA of 162.71 Million CNY for 2024 Q2, up 110.02% from previous quarter.

Annual EBITDA Chart of Liaoning Cheng Da Co., Ltd. (2023 - 1993)

Historical Annual EBITDA of Liaoning Cheng Da Co., Ltd. (2023 - 1993)

Year EBITDA EBITDA Growth
2023 465.75 Million CNY -92.16%
2022 1.24 Billion CNY -2.52%
2021 3 Billion CNY -30.91%
2020 3.66 Billion CNY 115.0%
2019 2.31 Billion CNY 48.15%
2018 1.56 Billion CNY -38.84%
2017 2.41 Billion CNY 22.99%
2016 604.07 Million CNY 14.17%
2015 84.93 Million CNY 6.25%
2014 1.33 Billion CNY 13.35%
2013 1.39 Billion CNY 18.28%
2012 1.19 Billion CNY -60.19%
2011 3.17 Billion CNY 95.32%
2010 1.6 Billion CNY 3.1%
2009 1.55 Billion CNY 34.54%
2008 1.16 Billion CNY -52.06%
2007 2.42 Billion CNY 276.47%
2006 715 Million CNY 267.9%
2005 190.25 Million CNY 38.32%
2004 134.61 Million CNY 28.87%
2003 100.12 Million CNY -9.16%
2002 110.86 Million CNY -31.46%
2001 159.9 Million CNY -29.98%
2000 226.86 Million CNY 151.64%
1999 90.87 Million CNY -6.23%
1998 92.31 Million CNY 0.21%
1997 97.13 Million CNY 39.48%
1996 69.63 Million CNY -3.04%
1995 71.82 Million CNY -93.52%
1994 1.1 Billion CNY 70.27%
1993 651.3 Million CNY 0.0%

Peer EBITDA Comparison of Liaoning Cheng Da Co., Ltd.

Name EBITDA EBITDA Difference
China Meheco Group Co., Ltd. 2.27 Billion CNY 79.514%
Shanghai Pharmaceuticals Holding Co., Ltd 11.24 Billion CNY 95.858%
Guangxi LiuYao Group Co., Ltd 1.28 Billion CNY 63.754%